{"nct_id":"NCT07150091","title":"Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2022-07-19","start_date_type":"ACTUAL","primary_completion_date":"2025-04-17","primary_completion_date_type":"ACTUAL","completion_date":"2027-03-11","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}